The Mass Spectrometry Core will provide the powerful tools of modern mass spectrometry to DPPG investigators. Quantification of both lipids and oxidized amino acids by GC/MS remains a mainstay of the Core. The Core will also permit structural identification and quantitation of high density lipoprotein (HDL)- related biomolecules, including apolipoprotein A-l and serum amyloid protein. Over the past two years, Core personnel have also become proficient in 2-dimensional liquid chromatography-electrospray ionization- MS/MS analysis (shotgun proteomics) of complex biological mixtures of proteins, and we anticipate that all investigators will take advantage of this capability in the next funding period. In addition to providing instrumental capabilities, Mass Spectrometry Core staff will provide consultation and collaboration on the application of mass spectrometry to the DPPG research program, and this will include development of new analytical methods targeted at achieving research objectives of DPPG investigators. The Mass Spectrometry Core will optimize the efficiency and cost-effectiveness through which these services are provided to DPPG investigators by providing a central laboratory. This avoids the need for individual DPPG investigators to maintain the required instrumentation in their own laboratories and avoids the high cost of commercial mass spectrometric services. By centralizing and standardizing procedures, the Mass Spectrometry Core will provide a common set of analytical tools that will lead to a unified understanding of molecular mechanisms involved in physiologic and pathophysiologic processes of diabetic vascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL092969-52
Application #
8375979
Study Section
Special Emphasis Panel (ZHL1-PPG-J)
Project Start
Project End
2014-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
52
Fiscal Year
2012
Total Cost
$149,342
Indirect Cost
$59,447
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ronsein, Graziella E; Heinecke, Jay W (2017) Time to ditch HDL-C as a measure of HDL function? Curr Opin Lipidol 28:414-418
Heinecke, Jay W; Bornfeldt, Karin E (2017) A Long Road Ahead for Discovering New HDL Metrics That Reflect Cardiovascular Disease Risk. J Am Coll Cardiol 70:179-181
Ronsein, Graziella E; Vaisar, Tomáš (2017) Inflammation, remodeling, and other factors affecting HDL cholesterol efflux. Curr Opin Lipidol 28:52-59
Wall, Valerie Z; Barnhart, Shelley; Kramer, Farah et al. (2017) Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (?C20)-acyl chains in macrophages. J Lipid Res 58:1174-1185
Pamir, Nathalie; Hutchins, Patrick M; Ronsein, Graziella E et al. (2017) Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight 2:
Den Hartigh, Laura J; Omer, Mohamed; Goodspeed, Leela et al. (2017) Adipocyte-Specific Deficiency of NADPH Oxidase 4 Delays the Onset of Insulin Resistance and Attenuates Adipose Tissue Inflammation in Obesity. Arterioscler Thromb Vasc Biol 37:466-475
Ruparelia, Neil; Chai, Joshua T; Fisher, Edward A et al. (2017) Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol 14:133-144
Kraakman, Michael J; Lee, Man Ks; Al-Sharea, Annas et al. (2017) Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest 127:2133-2147
Kothari, Vishal; Bornfeldt, Karin E (2017) Liver Kinase B1 Links Macrophage Metabolism Sensing and Atherosclerosis. Circ Res 121:1024-1026
Pamir, Nathalie; Hutchins, Patrick; Ronsein, Graziella et al. (2016) Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res 57:246-57

Showing the most recent 10 out of 113 publications